His primary areas of study are Molecular biology, Cancer research, Transcription factor, Y box binding protein 1 and Angiogenesis. Hiroto Izumi has researched Molecular biology in several fields, including CAAT box and DNA damage. His Cancer research research integrates issues from Cell culture, Gene expression, Cancer cell, Immunology and Kinase.
As a member of one scientific family, Hiroto Izumi mostly works in the field of Transcription factor, focusing on Cell biology and, on occasion, Bicarbonate transporter protein, Metastasis and Monocarboxylate transporter. The Y box binding protein 1 study combines topics in areas such as Regulation of gene expression and DNA repair. His Angiogenesis research includes themes of Tumor necrosis factor alpha, Basic fibroblast growth factor and Interleukin 8.
His primary scientific interests are in Cancer research, Molecular biology, Pathology, Transcription factor and Internal medicine. His study in Cancer research is interdisciplinary in nature, drawing from both Cancer cell, Cancer, Cell culture, Gene knockdown and Cell growth. His biological study spans a wide range of topics, including CAAT box, DNA, DNA damage and Transcription, Gene.
His Pathology study integrates concerns from other disciplines, such as Survival analysis, Lung and Adenocarcinoma. In his research on the topic of Transcription factor, Transactivation is strongly related with Promoter. His studies in Internal medicine integrate themes in fields like Endocrinology and Oncology.
Hiroto Izumi mainly investigates Cancer research, Lung, Internal medicine, Pharmacology and Intratracheal instillation. His Cancer research research incorporates elements of Protein kinase B, Phosphorylation, Gene expression, Cancer cell and Downregulation and upregulation. His Downregulation and upregulation research focuses on Glioma and how it relates to Cell culture and Cell growth.
His work in the fields of Pulmonary toxicity overlaps with other areas such as Surfactant protein D. His Internal medicine research includes elements of Gastroenterology, Endocrinology and Antibody. His research is interdisciplinary, bridging the disciplines of Molecular biology and Gene.
Hiroto Izumi mainly investigates Cancer research, Cell growth, Protein kinase B, Gene silencing and Phosphorylation. His research in Cancer research intersects with topics in Cancer cell, Internalization and Drug resistance. His Protein kinase B study incorporates themes from Differentiation-inducing factor, Cell culture, Downregulation and upregulation and Glioma.
Hiroto Izumi interconnects Tamoxifen, Breast cancer, Fulvestrant and Everolimus in the investigation of issues within Phosphorylation. His Cytoplasm study introduces a deeper knowledge of Cell biology. He has included themes like Replication protein A, Binding protein, Immunoprecipitation, Ribonucleoprotein and DNA in his Cell biology study.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Cellular pH regulators: potentially promising molecular targets for cancer chemotherapy
Hiroto Izumi;Takayuki Torigoe;Hiroshi Ishiguchi;Hidetaka Uramoto.
Cancer Treatment Reviews (2003)
The pleiotropic functions of the Y-box-binding protein, YB-1.
Kimitoshi Kohno;Hiroto Izumi;Takeshi Uchiumi;Megumi Ashizuka.
Induction of Vascular Endothelial Growth Factor by Tumor Necrosis Factor α in Human Glioma Cells POSSIBLE ROLES OF SP-1
Masahiro Ryuto;Mayumi Ono;Hiroto Izumi;Shigeo Yoshida.
Journal of Biological Chemistry (1996)
Involvement of the transcription factor NF-kappaB in tubular morphogenesis of human microvascular endothelial cells by oxidative stress.
Tadahisa Shono;Mayumi Ono;Hiroto Izumi;Sei Ichiro Jimi.
Molecular and Cellular Biology (1996)
Transcription factor Y-box binding protein 1 binds preferentially to cisplatin-modified DNA and interacts with proliferating cell nuclear antigen.
Tomoko Ise;Gunji Nagatani;Toshihiro Imamura;Ken Kato.
Cancer Research (1999)
P53 physically interacts with mitochondrial transcription factor A and differentially regulates binding to damaged DNA.
Yoichiro Yoshida;Hiroto Izumi;Takayuki Torigoe;Hiroshi Ishiguchi.
Cancer Research (2003)
Review of toxicity studies of carbon nanotubes.
Norihiro Kobayashi;Hiroto Izumi;Yasuo Morimoto.
Journal of Occupational Health (2017)
Direct interaction of p53 with the Y-box binding protein, YB-1: a mechanism for regulation of human gene expression.
T Okamoto;H Izumi;T Imamura;H Takano.
Monocarboxylate transporters 1 and 4 are involved in the invasion activity of human lung cancer cells.
Hiroto Izumi;Mayu Takahashi;Hidetaka Uramoto;Yoshifumi Nakayama.
Cancer Science (2011)
Enhanced coexpression of YB-1 and DNA topoisomerase II α genes in human colorectal carcinomas
Kazunori Shibao;Hiroshi Takano;Yoshifumi Nakayama;Keisuke Okazaki.
International Journal of Cancer (1999)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: